MoneyWorks4Me

Kwality Pharmaceuticals informs about disclosure

10 Mar 2026 Evaluate
Kwality Pharmaceuticals has informed that it enclosed Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Updation on Bioequivalence (BE) Program- Successful Completion of Phase 1 by Kwality Pharmaceuticals. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1759.10
Dr. Reddys Labs. 1230.50
Cipla 1313.70
Lupin 1946.00
Zydus Lifesciences 1139.00
View more..